XML 47 R33.htm IDEA: XBRL DOCUMENT
v3.22.4

Government Grant - Additional Information (Details) - USD ($) $ in Thousands |  | 12 Months Ended
--- | --- | ---
Aug. 01, 2021 | Dec. 31, 2022 | Dec. 31, 2021
Government Grant [Line Items] |  |  |
Grant receivable |  | $ 105 | $ 153
NIDA |  |  |
Government Grant [Line Items] |  |  |
Grant awarded | $ 300 | 2,500 |
ORCA-V1 Clinical Study Costs |  |  |
Government Grant [Line Items] |  |  |
Grant awarded |  | 2,800 |
NIDA/NIH |  |  |
Government Grant [Line Items] |  |  |
Reduction in R&D expense |  | 1,300 | $ 300
Grant receivable |  | $ 100 |

X
- Definition Government grant. + References No definition available. + Details
Name: | achv_GovernmentGrantLineItems
Namespace Prefix: | achv_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Grant awarded. + References No definition available. + Details
Name: | achv_GrantAwarded
Namespace Prefix: | achv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and development expenses increase (decrease). + References No definition available. + Details
Name: | achv_ResearchAndDevelopmentExpensesIncreaseDecrease
Namespace Prefix: | achv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)(a)(4)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_GrantsReceivableCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_RegulatoryAgencyAxis=achv_NationalInstituteOnDrugAbuseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RegulatoryAgencyAxis=achv_ORCAV1ClinicalStudyCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RegulatoryAgencyAxis=achv_NationalInstituteOnDrugAbuseAndNationalInstitutesOfHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |